Literature DB >> 22945505

Within-person variability in high-sensitivity C-reactive protein.

Julie K Bower, Mariana Lazo, Stephen P Juraschek, Elizabeth Selvin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22945505      PMCID： PMC3613132          DOI： 10.1001/archinternmed.2012.3712

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  8 in total

1.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 2.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

Authors:  Paul M Ridker
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 3.  Inflammation as a cardiovascular risk factor.

Authors:  James T Willerson; Paul M Ridker
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

4.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Philip Greenland; Joseph S Alpert; George A Beller; Emelia J Benjamin; Matthew J Budoff; Zahi A Fayad; Elyse Foster; Mark A Hlatky; John McB Hodgson; Frederick G Kushner; Michael S Lauer; Leslee J Shaw; Sidney C Smith; Allen J Taylor; William S Weintraub; Nanette K Wenger; Alice K Jacobs
Journal:  Circulation       Date:  2010-11-15       Impact factor: 29.690

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Fluctuating inflammatory markers in patients with stable ischemic heart disease.

Authors:  Peter Bogaty; James M Brophy; Luce Boyer; Serge Simard; Lawrence Joseph; Fernand Bertrand; Gilles R Dagenais
Journal:  Arch Intern Med       Date:  2005-01-24

7.  Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris.

Authors:  M P de Maat; A C de Bart; B C Hennis; P Meijer; A C Havelaar; P G Mulder; C Kluft
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-09       Impact factor: 8.311

8.  From here to JUPITER: identifying new patients for statin therapy using data from the 1999-2004 National Health and Nutrition Examination Survey.

Authors:  Erica S Spatz; Maureen E Canavan; Mayur M Desai
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-01-13
  8 in total
  21 in total

1.  GlycA: A New Biomarker for Systemic Inflammation and Cardiovascular Disease (CVD) Risk Assessment.

Authors:  Rami A Ballout; Alan T Remaley
Journal:  J Lab Precis Med       Date:  2020-04-20

Review 2.  Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium.

Authors:  Waqas T Qureshi; Jamal S Rana; Joseph Yeboah; Usama Bin Nasir; Mouaz H Al-Mallah
Journal:  Curr Cardiol Rep       Date:  2015-12       Impact factor: 2.931

3.  Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality.

Authors:  Christina M Parrinello; Pamela L Lutsey; Christie M Ballantyne; Aaron R Folsom; James S Pankow; Elizabeth Selvin
Journal:  Am Heart J       Date:  2015-04-18       Impact factor: 4.749

4.  Effect of change in systolic blood pressure between clinic visits on estimated 10-year cardiovascular disease risk.

Authors:  Siqin Ye; Y Claire Wang; Daichi Shimbo; Jonathan D Newman; Emily B Levitan; Paul Muntner
Journal:  J Am Soc Hypertens       Date:  2013-12-19

5.  Medical decision making and the counting of uncertainty.

Authors:  Siqin Ye
Journal:  Circulation       Date:  2014-04-17       Impact factor: 29.690

Review 6.  Pathways Forward in Cardiovascular Disease Prevention One and a Half Years After Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention Guidelines.

Authors:  Miguel Cainzos-Achirica; Chintan S Desai; Libin Wang; Michael J Blaha; Francisco Lopez-Jimenez; Stephen L Kopecky; Roger S Blumenthal; Seth S Martin
Journal:  Mayo Clin Proc       Date:  2015-08-11       Impact factor: 7.616

7.  Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.

Authors:  A R Folsom; P L Lutsey; S R Heckbert; K Poudel; S Basu; R C Hoogeveen; M Cushman; C M Ballantyne
Journal:  J Thromb Haemost       Date:  2018-08-11       Impact factor: 5.824

8.  Within-person reproducibility of proteoforms related to inflammation and renal dysfunction.

Authors:  Jie Gao; Adrian McCann; Johnny Laupsa-Borge; Ottar Nygård; Per Magne Ueland; Klaus Meyer
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

9.  Effects of Dietary Patterns on Biomarkers of Inflammation and Immune Responses: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Liselot Koelman; Caue Egea Rodrigues; Krasimira Aleksandrova
Journal:  Adv Nutr       Date:  2022-02-01       Impact factor: 11.567

10.  A Low-Sodium DASH Dietary Pattern Affects Serum Markers of Inflammation and Mineral Metabolism in Adults with Elevated Blood Pressure.

Authors:  Valerie K Sullivan; Lawrence J Appel; Jesse C Seegmiller; Scott T McClure; Casey M Rebholz
Journal:  J Nutr       Date:  2021-10-01       Impact factor: 4.687
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.